GLP1 receptor agonists are widely prescribed to help control blood sugar levels and support weight loss. While these ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

According to Sarah Marjoram, MS, RDN, a dietitian who specializes in food as medicine, “When it comes to improving health, ...

For decades, the US healthcare system has struggled to address the diet-related chronic illnesses affecting nearly half of all adults. That changed in recent years with the discovery of Ozempic and ...